India HbA1c Market Research Report Information by Product Type (Reagents & Kits and Instruments [Bench Top Devices and Hand-Held Devices), by Technology (Ion-Exchange HPLC, Immunoassay, Boronate Affinity HPLC, Enzymatic Assay, Turbidimetric Inhibition Immunoassay (TINIA), and Others), by Application (Thalassemia, Sickle Cell Anaemia, and Type 2 Diabetes), by End User (Hospitals and Clinics, Diagnostic Laboratories, and Others) - Forecast till 2032

India HbA1c Market Overview

India HbA1c market size was valued at USD 0.11 billion in 2022. The India HbA1c market industry is projected to grow from USD 0.12 billion in 2023 to USD 0.29 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.49% during the forecast period (2023 - 2032).

The India market growth is propelled by several key factors, notably the rising prevalence of type 2 diabetes and increased prevalence of thalassemia and sickle cell among India.

 Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

India HbA1c Market Trends

• Increased prevalence of thalassemia and sickle cell among India

HbA1c testing is a crucial tool for type 2 diabetes patients to monitor their blood sugar control and manage their condition effectively. Regular HbA1c monitoring assists physicians and patients to assess diabetes management, adjust treatment as needed, and reduce the risk of complications. India is often referred to as the “Diabetes Capital of the World,” and the factors that are driving India to become a diabetes capital are India has the largest population in the world and India is undergoing rapid urbanization, leading to lifestyle changes.

Moreover, India has a high burden of thalassemia and sickle cell diseases, with a significant number of individuals affected by these conditions. According to estimates, India has the highest number of thalassemia patients in the world, with approximately 50 million carriers and over 10,000 thalassemia major patients. The increasing prevalence of these conditions in the country has led to a rising demand for HBa1c testing. Healthcare providers and laboratories are increasingly performing these tests to diagnose and monitor individuals with thalassemia and sickle cell diseases.

Thus, the demand for HbA1c testing among Indians is increasing due to rising prevalence of type 2 diabetes, thalassemia, and sickle cell disease.

India HbA1c Market Segment Insights

India HbA1c Market Product Type Insights

Based on product type, the India HbA1c market is segmented into reagents & kits and instruments. Furthermore, the instrument segment bifurcated into bench top devices and hand-held devices. Reagents & kits held the largest market share in 2022 and instruments is anticipated to register the highest CAGR from 2022 to 2032. This growth is driven by rising diabetes prevalence and advancement in technology to development of more accurate and user-friendly HbA1c testing kits and devices. For instance, in November 2021, as per the World Health Organization, there were an estimated 77 million people suffering from type 2 diabetes, especially those over the age of 18.

India HbA1c Market Technology Insights

Based on technology, the India HbA1c market has been segmented into ion-exchange HPLC, immunoassay, boronate affinity HPLC, enzymatic assay, turbidimetric inhibition immunoassay (TINIA), and others. Immunoassay held the largest market share in 2022 and turbidimetric inhibition immunoassay is anticipated to register the highest CAGR from 2022 to 2032. This growth reflects due to some major factors such as increasing research and development activity across the country, quality control and regulatory compliance, and rising demand of accurate and reliable measurements of glycated hemoglobin levels.

FIGURE 2: INDIA HBA1C MARKET, BY TECHNOLOGY, 2022 & 2032 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

India HbA1c Market Application Insights

Based on application, the India HbA1c market has been segmented into thalassemia, sickle cell anaemia, and type 2 diabetes. Type 2 diabetes held the largest market share in 2022 and is anticipated to register the highest CAGR from 2022 to 2032. This is due to the increased prevalence of thalassemia in India and the growing prevalence of sickle cell anemia in India. Furthermore, patient education and awareness for early diagnosis of type 2 diabetes and a sedentary lifestyle are the major factors contributing to the increase in type 2 diabetes among Indians, fueling the growth of the market during the forecast period.

India HbA1c Market End User Insights

Based on end user, the India HbA1c market is segmented into hospitals and clinics, diagnostic laboratories, and others. Hospitals and clinics held the largest market share in 2022 due to diagnostic accuracy and reliability and their rising adaptation to integrated healthcare services. Moreover, the diagnostic laboratories segment is anticipated to register the highest CAGR during the forecast period because of rising awareness regarding high accuracy, reliability, and consistency in HbA1c  testing results.

India HbA1c Market Key Market Players & Competitive Insights

The India HbA1c testing market is distinguished by the presence of numerous local players catering to HbA1c testing products that are evolving at a rapid pace. Furthermore, the rising prevalence of type 2 diabetes and increased prevalence of thalassemia and sickle cell among India is further driving the growth of India HbA1c testing market during the forecast period. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs.

Furthermore, PTS Diagnostics (US) manufactures point-of-care biometric testing devices. The company offers diagnostic products and accessories to the healthcare industry through its signature products, which include the CardioChek family of lipid and glucose analyzers & products, A1CNow + systems, portable analyzers that provide a HbA1c measurement, a tobacco-detection device, and many other devices. Additionally, PTS Diagnostics offers the PTS ConnectTM solution, a turnkey population health management (PHM) platform, to urgent care centers, retail clinics, and health and wellness enterprises. Moreover, the company launched the A1CNow+ Controls for the A1CNow+ Test System. A1CNow+ Controls can be kept at room temperature for seven days, in the refrigerator for eight months, or in the freezer for up to three years. Within minutes, both solution’s levels each in a dropper-style vial can be used. Its goal is to ensure accurate A1C measurements. Customers can buy this product from the US, EU, UK, and including India.

Key Companies in the India HbA1c market includes.

• Siemens Healthineers AG (Germany)


• PTS Diagnostics (US)


• ARKRAY, Inc (Japan)


• Abbott (US)


• Bio-Rad Laboratories, Inc (US)


• Transasia Bio-Medicals (India)


• Hoffmann-La Roche Ltd. (Switzerland)


• Beckman Coulter, Inc. (US)


• LumiraDx (UK)


• HemoCue AB (Sweden)

India HbA1c Market Industry Developments

February 2022: Abbott (US) moved into collaboration with health-tech partners BeatO (India), PharmEasy (India), Sugar.fit (India), GOQii (India), Zyla Health (India), 1MG (India), Healthifyme (India), and Fitterfly (India) to lead a new era of holistic diabetes management. Through these collaborations, Abbott aims to offer glucose monitoring solutions to 8 million people living with diabetes, of which around 6.5 million users can access through 1MG and PharmEasy.

March 2020: PTS Diagnostics (US) launched the A1CNow+ Controls for the A1CNow+ Test System. A1CNow+ Controls can be kept at room temperature for seven days, in the refrigerator for eight months, or in the freezer for up to three years. Within minutes, both solution’s levels each in a dropper-style vial can be used. Its goal is to ensure accurate A1C measurements. Customers can buy this product from the US, EU, UK, and including India.

India HbA1c Market Segmentation

India HbA1c Market Product Type Outlook

• Reagents & Kits


• Instruments
  
  
  
  • Bench Top Devices  
  
  
  • Hand-Held Devices 
  
  
  
  

India HbA1c Market Technology Outlook

• Ion-Exchange HPLC


• Immunoassay


• Boronate affinity HPLC


• Enzymatic Assay


• Turbidimetric Inhibition Immunoassay (TINIA)


• Others

India HbA1c Market Application Outlook

• Thalassemia


• Sickle Cell Anaemia


• Type 2 Diabetes

India HbA1c Market End User Outlook

• Hospitals and Clinics


• Diagnostic Laboratories


• Others